Pre-treatment neutrophil-to-lymphocyte ratio affects survival in patients with advanced hepatocellular carcinoma treated with sorafenib
Crossref DOI link: https://doi.org/10.1007/s12032-014-0264-5
Published Online: 2014-10-02
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
da Fonseca, Leonardo Gomes
Barroso-Sousa, Romulado
Bento, Afonso da Silva Alves
Blanco, Bruna Paccola
Valente, Gabriel Luis
Pfiffer, Tulio Eduardo Flesch
Hoff, Paulo Marcelo
Sabbaga, Jorge
Text and Data Mining valid from 2014-10-02